Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS1033 as Adjuvant Therapy in Diabetic Polyneuropathy
NCT07475065Phase 3Not yet recruiting
- Sponsor
- Universitas Sebelas Maret
- Start
- Mar 2026
- Primary completion
- May 2026
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of DLBS1033 in diabetic polyneuropathy (DPN), sponsored by Universitas Sebelas Maret. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
DLBS1033
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT07475065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07475065.